Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, and Viral-associated cancers and disorders.
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
Impact of initial chemotherapy regimen on outcomes for patients with double‐expressor lymphoma: A multi‐center analysis
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation
Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-World Analysis
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a “real world” study
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma